In agreement with this hypothesis, high TMB levels correlated with response to immunotherapy only in cancer types where CD8 T-cell levels positively correlated with neoantigen load, including melanoma, lung, and bladder cancers [33]. This evidence concerns the gene CD8A and urinary bladder carcinoma.